References
- D. Schadendorf, A. C. J. van Akkooi, and C. Berking, Lancet 392, 971–984 (2018).
- E. Hodis, I. R. Watson, and G. V. Kryukov, Cell 150, 251–263 (2012).
- M. Cargnello and P. P. Roux, Microbiol. Mol. Biol. Rev. 75, 50–83 (2011).
- K. Flores, S. S. Yadav, and A. A. Katz, Neuroendocrinology 108, 121–131 (2019).
- N. J. Ives, R. L. Stowe, and P. Lorigan, J. Clin. Oncol. 25, 5426–5434 (2007).
- Y. Q. Zhang, H. Yang, and W. D. Sun, Chin. J. Integr. Med. 24, 47–55 (2018).
- J. Bao, R. Ding, and L. Zou, Am. J. Chin. Med. 44, 1043–1061 (2016).
- V. Nanni, L. Canuti, and A. Gismondi, Phytomedicine 46, 1–10 (2018).
- Y. Zheng, H. Wang, and M. Yang, Int. J. Mol. Sci. 19, 2422 (2018).
- N. P. Gullett, A. R. Ruhul Amin, and S. Bayraktar, Semin. Oncol. 37, 258–281 (2010).
- M. Liu, P. E. Hansen, and G. Wang, Molecules 20, 754–779 (2015).
- X. Mi, C. Wang, and C. Sun, Oncotarget 8, 31297–31304 (2017).
- J. H. Koo, H. T. Kim, and H. Y. Yoon, Exp. Mol. Med. 40, 313–319 (2008).
- T. Krajnovic, G. N. Kaluderovic, and L. A. Wessjohann, Pharmacol. Res. 105, 62–73 (2016).
- K. Zimmermann, J. Baldinger, and B. Mayerhofer, Free Radic. Biol. Med. 88, 417–426 (2015).
- X. Huang, J. Wang, and X. Chen, Front Pharmacol. 9, 199 (2018).
- S. Lust, B. Vanhoecke, and V. A. N. G. M, Anticancer Res. 29, 3797–3805 (2009).
- S. Elmore, Toxicol. Pathol. 35, 495–516 (2007).
- W. A. Maltese and J. H. Overmeyer, Am. J. Pathol. 184, 1630–1642 (2014).
- Y. Shikata, T. Yoshimaru, and M. Komatsu, Cancer Sci. 108, 785–794 (2017).
- Y. Sasazawa, S. Kanagaki, and E. Tashiro, ACS. Chem. Biol. 7, 892–900 (2012).
- J. Hong, K. Kim, and J. H. Kim, Int. J. Vasc. Med. 2017, 2049217 (2017).
- H. P. Harding, Y. Zhang and D. Ron, Nature 397, 271–274 (1999).
- K. S. Suh, S. Chon and E. M. Choi, J. Appl. Toxicol. 38, 180–192 (2018).